Cyclic nucleotide signaling in polycystic kidney disease. - Wikidata - wikimedia - TriplyDB

Cyclic nucleotide signaling in polycystic kidney disease.

Cyclic nucleotide signaling in polycystic kidney disease.

http://www.wikidata.org/entity/Q37051278

about

Mechanisms of nephronophthisis and related ciliopathies Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases Phosphodiesterase 1A modulates cystogenesis in zebrafish.Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.The cell biology of polycystic kidney disease Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.Effects of hydration in rats and mice with polycystic kidney disease.Cilium, centrosome and cell cycle regulation in polycystic kidney disease.Neuronal ciliary signaling in homeostasis and disease.Vasopressin and disruption of calcium signalling in polycystic kidney disease.Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.Vasopressin inhibits apoptosis in renal collecting duct cells.Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies A cAMP and CREB-mediated feed-forward mechanism regulates GSK3β in polycystic kidney disease.Calcium-mediated mechanisms of cystic expansion.Drug discovery for polycystic kidney disease From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease.Vasopressin: a novel target for the prevention and retardation of kidney disease?Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation.B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.Genetic Mechanisms of ADPKD.Cell Proliferation and Apoptosis in ADPKD.Generation and phenotypic characterization of Pde1a mutant mice.The vasopressin system: new insights for patients with kidney diseases: Epidemiological evidence and therapeutic perspectives.Novel treatments of autosomal dominant polycystic kidney disease Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination.Expanding the role of vasopressin antagonism in polycystic kidney diseases: From adults to children?The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.Activation of Calcium-Sensing Receptor increases intracellular calcium and decreases cAMP and mTOR in PKD1 deficient cells.

P2860

Q24634201-0AA94EDD-9D96-44DB-B088-074FBB6F325A Q28591325-D02FA728-2094-4EE3-A0D4-54D4231F12AB Q30588457-825111A3-82CC-4B37-A0D9-DA0C779D3AAD Q33872509-9A741234-D202-443A-8B4F-B54C242C9D30 Q34149966-9C1D51D6-98B5-4D65-8B8A-C823279DD541 Q34858052-8804CFFD-21C8-4A22-8EEC-773BF5581162 Q35035244-D6278EA1-4949-4FF0-9103-5BAFC79CF5C1 Q35112926-1B3BDDD5-E254-4B52-B0F1-E5F8DFB518BF Q35952274-E7664A79-0656-4F08-ADE2-71D672DBDD83 Q35962991-6370CF5B-3712-4FB5-890E-E77E78A7ADA8 Q36454170-C8415D40-C2F5-410D-9490-2AB2BE435A24 Q36527903-816489B4-9932-4875-A278-ACD87FB55904 Q36746073-C5E809B8-E50F-4586-B493-CFF6F6881C91 Q36849194-4E6C64CB-9B03-417B-9390-E08493695527 Q37529873-3AFF9415-DBAC-48B5-90AB-A75E04551042 Q37798910-A4CF77EE-FA00-48D6-B44C-2DC061149EE6 Q37885161-E462B992-E25B-4732-B587-B3B269C55318 Q38076051-AEDD0DFA-A54C-4CB5-8CC8-145BA4E21611 Q38084471-5B039284-40AA-4675-A894-325CE58AE48D Q38171193-7CB3B1DD-316C-4576-BCCF-7ED9E085BB18 Q38325544-2CCDD0A8-2055-4A6F-8D51-ED30F2EA78CF Q38833791-26DA8C14-B309-471E-9DC6-D044749E5D76 Q38978453-52F1D0CF-7A5A-43DE-AF4D-701872B5C429 Q38978456-0705A4BA-955B-40D8-8DBE-AF8717A610C0 Q41153428-3C621798-7336-46F5-A000-63DBB4547C1A Q41998074-9372D8F6-7C5A-49D0-96BA-90AE7B7A1775 Q42556481-4CBE472F-4865-429A-9304-CF2701D9BB55 Q48205666-5266D343-9B01-455D-A233-D47301A7E0A1 Q48216298-1125D736-5571-4223-88B7-2A2E366D6613 Q50944400-EA8B46DC-5126-468B-8419-E262AFDFED2A Q55403111-17E8202B-0A9F-405E-A520-1ED112CF0F6F

P2860

Cyclic nucleotide signaling in polycystic kidney disease.

http://www.wikidata.org/entity/Q37051278

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Cyclic nucleotide signaling in polycystic kidney disease.

@en

Cyclic nucleotide signaling in polycystic kidney disease.

@nl

type

label

Cyclic nucleotide signaling in polycystic kidney disease.

@en

Cyclic nucleotide signaling in polycystic kidney disease.

@nl

prefLabel

Cyclic nucleotide signaling in polycystic kidney disease.

@en

Cyclic nucleotide signaling in polycystic kidney disease.

@nl

P1433

Q37051278-9D2E3D32-D9CC-49EC-9BEF-E0C37BFFDFC7

P1476

Q37051278-836F88AD-DB89-4B90-A0B1-8B7DE9D1F9FE

P2093

Q37051278-89EE3524-DD4C-48AF-9913-A57528F30CC2

Q37051278-A30AE90D-12A9-4E40-90BC-3080EC7D1F8E

Q37051278-AB945FC2-9454-4BAE-B164-0792F44FA94B

Q37051278-DEA06B0F-A187-4FFB-B1FE-CCF0628A0E14

P2860

Q37051278-0138B1B3-6236-41D1-AB15-62BE18FECCA2

Q37051278-04D3F68C-CF52-4BE6-B04F-90A6ECF7CD64

Q37051278-061CB507-403F-459F-AD1F-6A0ABFA8085C

Q37051278-07451B4E-5ECD-4470-9EF7-D3BFADCF33F4

Q37051278-074C8D9C-9026-48E6-9F0F-F2FAE8AD5BDA

Q37051278-0A5C0277-582D-41EA-97B6-33C646F01395

Q37051278-0FDD4E28-A118-4D32-915D-A3E00E1D0A5E

Q37051278-10E1B170-55C7-43B3-8FB5-25C2B9C7E991

Q37051278-13417918-45C6-47F5-953A-F800C9F8CBD7

Q37051278-1A6DAA16-58FB-480A-9B29-8DE9E879EFC4

P2888

Q37051278-1B09C4CB-443F-4462-AD4B-B7195E67B577

P304

Q37051278-CFE86350-889E-4D35-AAD1-6471196573C1

P31

Q37051278-52DB50E7-C35A-47A8-B510-107CDC2A618E

P356

Q37051278-23CDEBE5-B47C-4C76-8F96-F6FF3A919CD2

P407

Q37051278-DBB102BD-6E26-4E9C-A51C-6880FA6D1D5B

P433

Q37051278-C2642A95-0BD7-483A-98A3-5E1A3D2D35E8

P478

Q37051278-24B6144A-1CA8-41A0-A2AC-CB698D6C501B

P577

Q37051278-200CF681-1C75-4F23-9D47-D15A60D64B0E

P5875

Q37051278-749FE5D6-2D54-488B-B13C-048547C47163

P6179

Q37051278-856F8229-43C4-473F-92A5-3CCDE351B3D3

P698

Q37051278-D66575EC-460A-47FE-B297-67472AE81DB4

P932

Q37051278-F895086B-1767-4E7B-AE08-DC5C8D841C01

P356

P1433

Kidney International

P1476

Cyclic nucleotide signaling in polycystic kidney disease.

@en

P2093

Christopher J Ward

http://www.w3.org/2001/XMLSchema#string

Peter C Harris

http://www.w3.org/2001/XMLSchema#string

Vicente E Torres

http://www.w3.org/2001/XMLSchema#string

Xiaofang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

PrKX is a novel catalytic subunit of the cAMP-dependent protein kinase regulated by the regulatory subunit type I

Molecular cloning, genomic positioning, promoter identification, and characterization of the novel cyclic amp-specific phosphodiesterase PDE4A10

Protein kinase X (PRKX) can rescue the effects of polycystic kidney disease-1 gene (PKD1) deficiency

Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells. Identification and characterization of a novel PDE4D5 promoter

Identification and characterisation of a human calmodulin-stimulated phosphodiesterase PDE1B1

Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents

Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1)

Ca2+-calmodulin-dependent phosphodiesterase (PDE1): current perspectives

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

Minireview: PRKAR1A: normal and abnormal functions

P2888

P304

129-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/KI.2009.438

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38099835

http://www.w3.org/2001/XMLSchema#string

P6179

1014630665

http://www.w3.org/2001/XMLSchema#string

P698

19924104

http://www.w3.org/2001/XMLSchema#string

P932

3725619

http://www.w3.org/2001/XMLSchema#string